ArticleDevelopment (Cambridge, England)2016

Tril targets Smad7 for degradation to allow hematopoietic specification in Xenopus embryos.

Yangsook Song Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.